Analysts' Actions -- Anthem, Gilead Sciences, International Paper, Wayfair and More

RATINGS CHANGES

Anthem (ANTM) was upgraded to buy from neutral at Goldman Sachs. $168 price target. The stock is trading at a 25% discount to its peers and should be able to boost prices with Express Scripts (ESRX) , Goldman said. 

Comerica (CMA) was upgraded to outperform from market perform at FBR Capital Markets. $48 price target. Sentiment is low, but the company is trading at a 12% discount to tangible book value, FBR said. 

Fortinet (FTNT) was downgraded to neutral from overweight at Piper Jaffray. $30 price target. Waning demand will likely pressure margins, Piper said.

Genesco (GCO) was upgraded to overweight from neutral at Piper Jaffray. $65 price target. The company can expand margins and repurchase more stock, Piper said.

Gilead Sciences (GILD) was initiated with an outperform rating at Credit Suisse. $125 price target. The company is attractively valued at 7x earnings, Credit Suisse said.

International Paper (IP) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: IP.

Investment Technology (ITG) was upgraded to overweight from neutral at JPMorgan. $20 price target. The company is trading at 2x cash, and business trends are improving, JPMorgan said.

Liberty Media (LMCA) (LMCB) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: LMCA.

LifePoint Hospitals (LPNT) was downgraded to neutral from buy at Goldman Sachs. The valuation is less attractive, based on an $81 price target, Goldman said.

If you liked this article you might like

Equifax's Future Could Go in One of Two Directions

Equifax's Massive Data Breach Focuses Attention on Symantec's LifeLock

Anthem to Scale Back Obamacare Offerings in Missouri

Healthcare Management Stocks Look Too Pricey for Activists

Biotech Movers: Jazz Shares Lower Amid Notes Offering